Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study

Abstract: Aims. Angiotensin-converting enzyme inhibitors (ACEIs) are recommended as first-line therapy in patients with heart failure with reduced ejection fract

Saved in:

Bibliographic Details
Main Authors:	Fröhlich, Hanna (Author) , Henning, Felix (Author) , Täger, Tobias (Author) , Schellberg, Dieter (Author) , Corletto, Anna (Author) , Katus, Hugo (Author) , Frankenstein, Lutz (Author)
Format:	Article (Journal)
Language:	English
Published:	2018
In:	European heart journal - cardiovascular pharmacotherapy Year: 2018, Volume: 4, Issue: 2, Pages: 82-92
ISSN:	2055-6845
DOI:	10.1093/ehjcvp/pvx013
Online Access:	Verlag, Volltext: http://dx.doi.org/10.1093/ehjcvp/pvx013 Verlag, Volltext: https://academic.oup.com/ehjcvp/article/4/2/82/3798743
Author Notes:	Hanna Fröhlich, Felix Henning, Tobias Täger, Dieter Schellberg, Morten Grundtvig, Kevin Goode, Anna Corletto, Syed Kazmi, Torstein Hole, Hugo A. Katus, Dan Atar, John G. F. Cleland, Stefan Agewall, Lutz Frankenstein, and Andrew L. Clark

Description
Summary:	Abstract: Aims. Angiotensin-converting enzyme inhibitors (ACEIs) are recommended as first-line therapy in patients with heart failure with reduced ejection fract
Item Description:	Online publish-ahead-of-print 5 May 2017 Gesehen am 25.05.2018
Physical Description:	Online Resource
ISSN:	2055-6845
DOI:	10.1093/ehjcvp/pvx013